P.259 Retreatment with peginterferon alpha-2a (40KD) (Pegasys®) plus ribavirin (Copegus®) in patients in whom pegylated interferon alpha-2b (12KD)/ribavirin has failed: planned week-12 efficacy and safety analysis of the repeat study
2019 ◽
Vol 15
(6)
◽
pp. 595-600
◽
2015 ◽
Vol 54
(20)
◽
pp. 2551-2560
◽
2003 ◽
Vol 51
(1)
◽
pp. 81-86
◽
2009 ◽
Vol 17
(6)
◽
pp. 410-418
◽
2005 ◽
Vol 37
(11)
◽
pp. 882-885
◽